Jefferies and Citigroup lowered price targets on CACI shares, while MarketBeat aggregated the stock ratings.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies and Citigroup lowered price targets on CACI shares, while MarketBeat aggregated the stock ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CACI
American professional services and information technology company
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup and Jefferies Financial Group raised their price targets and issued buy ratings for Beauty.
- Multiple financial firms, including Jefferies, Bank of America, and Raymond James, issued price objective and rating updates on October 23, 2026.
- Citigroup reduced its price objective for ProKidney, with stock changes and ratings reported by Benzinga and MarketBeat.
- CACI received research reports, including rating and price target updates, from financial firms on October 6, 2026.
- Amphenol received multiple analyst upgrades and target price increases from firms including Citigroup, Bank of America, and Jefferies Financial Group on July 9, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.comCACI International (NYSE:CACI) Trading Up 4% – Should You Buy?